Trademark: 88728511
Status Date
Monday, July 17, 2023
Filing Date
Monday, December 16, 2019
Published for Opposition
Tuesday, April 21, 2020
Abandoned Date
Monday, July 17, 2023
5 Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders
Jul 17, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 17, 2023
Abandonment - No Use Statement Filed
Jan 5, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 4, 2023
Sou Extension 5 Granted
Dec 14, 2022
Sou Extension 5 Filed
Jan 4, 2023
Case Assigned To Intent To Use Paralegal
Dec 14, 2022
Teas Extension Received
Jun 17, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 15, 2022
Sou Extension 4 Granted
Jun 15, 2022
Sou Extension 4 Filed
Jun 15, 2022
Teas Extension Received
Dec 15, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 13, 2021
Sou Extension 3 Granted
Dec 13, 2021
Sou Extension 3 Filed
Dec 13, 2021
Teas Extension Received
Jun 17, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 15, 2021
Sou Extension 2 Granted
Jun 15, 2021
Sou Extension 2 Filed
Jun 15, 2021
Teas Extension Received
Dec 11, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 9, 2020
Sou Extension 1 Granted
Dec 9, 2020
Sou Extension 1 Filed
Dec 9, 2020
Teas Extension Received
Jun 16, 2020
Noa E-Mailed - Sou Required From Applicant
Apr 21, 2020
Official Gazette Publication Confirmation E-Mailed
Apr 21, 2020
Published For Opposition
Apr 1, 2020
Notification Of Notice Of Publication E-Mailed
Mar 16, 2020
Approved For Pub - Principal Register
Mar 16, 2020
Assigned To Examiner
Dec 19, 2019
New Application Office Supplied Data Entered
Dec 19, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24